CU24310B1 - Composiciones farmacéuticas que contienen dexketoprofeno y tramadol - Google Patents

Composiciones farmacéuticas que contienen dexketoprofeno y tramadol

Info

Publication number
CU24310B1
CU24310B1 CUP2015000081A CU20150081A CU24310B1 CU 24310 B1 CU24310 B1 CU 24310B1 CU P2015000081 A CUP2015000081 A CU P2015000081A CU 20150081 A CU20150081 A CU 20150081A CU 24310 B1 CU24310 B1 CU 24310B1
Authority
CU
Cuba
Prior art keywords
organic
group
inorganic
tramadol
corn starch
Prior art date
Application number
CUP2015000081A
Other languages
English (en)
Spanish (es)
Other versions
CU20150081A7 (es
Inventor
Tobías Kohl
Reinhard Schmitz
Original Assignee
Laboratorios Menarini S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47953547&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CU24310(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratorios Menarini S A filed Critical Laboratorios Menarini S A
Publication of CU20150081A7 publication Critical patent/CU20150081A7/es
Publication of CU24310B1 publication Critical patent/CU24310B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CUP2015000081A 2013-02-14 2014-02-06 Composiciones farmacéuticas que contienen dexketoprofeno y tramadol CU24310B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000210A ITMI20130210A1 (it) 2013-02-14 2013-02-14 Composizioni farmaceutiche contenenti dexketoprofene e tramadolo
PCT/EP2014/052342 WO2014124862A1 (fr) 2013-02-14 2014-02-06 Compositions pharmaceutiques contenant du dexkétoprofène et du tramadol

Publications (2)

Publication Number Publication Date
CU20150081A7 CU20150081A7 (es) 2016-01-29
CU24310B1 true CU24310B1 (es) 2018-01-10

Family

ID=47953547

Family Applications (1)

Application Number Title Priority Date Filing Date
CUP2015000081A CU24310B1 (es) 2013-02-14 2014-02-06 Composiciones farmacéuticas que contienen dexketoprofeno y tramadol

Country Status (45)

Country Link
US (1) US9949940B2 (fr)
EP (1) EP2956129B1 (fr)
JP (1) JP6297068B2 (fr)
KR (1) KR102262408B1 (fr)
CN (1) CN105007907B (fr)
AP (1) AP2015008616A0 (fr)
AR (1) AR094783A1 (fr)
AU (1) AU2014218110B2 (fr)
BR (1) BR112015018952B1 (fr)
CA (1) CA2900979C (fr)
CL (1) CL2015002251A1 (fr)
CR (1) CR20150411A (fr)
CU (1) CU24310B1 (fr)
CY (1) CY1120301T1 (fr)
DK (1) DK2956129T3 (fr)
EA (1) EA029709B1 (fr)
EC (1) ECSP15034660A (fr)
ES (1) ES2672986T3 (fr)
GE (1) GEP201706649B (fr)
HK (1) HK1216840A1 (fr)
HR (1) HRP20180974T1 (fr)
HU (1) HUE038417T2 (fr)
IL (1) IL240514B (fr)
IT (1) ITMI20130210A1 (fr)
LT (1) LT2956129T (fr)
MA (1) MA38335B1 (fr)
MX (1) MX353897B (fr)
MY (1) MY173102A (fr)
NI (1) NI201500105A (fr)
NO (1) NO2956129T3 (fr)
NZ (1) NZ710967A (fr)
PE (1) PE20151430A1 (fr)
PH (1) PH12015501766B1 (fr)
PL (1) PL2956129T3 (fr)
PT (1) PT2956129T (fr)
RS (1) RS57271B1 (fr)
SA (1) SA515360877B1 (fr)
SG (1) SG11201506291UA (fr)
SI (1) SI2956129T1 (fr)
TN (1) TN2015000345A1 (fr)
TR (1) TR201810114T4 (fr)
TW (1) TWI642430B (fr)
UA (1) UA115684C2 (fr)
UY (1) UY35324A (fr)
WO (1) WO2014124862A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4188337A1 (fr) 2020-07-31 2023-06-07 KRKA, d.d., Novo mesto Préparation contenant du dexkétoprofène et du tramadol et procédé de fabrication associé

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU661723B2 (en) 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US5516803A (en) 1991-10-30 1996-05-14 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US5968551A (en) 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
ES2058024B1 (es) 1992-11-10 1995-05-01 Menarini Lab Nuevo derivado arilpropionico, procedimiento de fabricacion del mismo y su utilizacion como analgesico.
DE19530575A1 (de) 1995-08-19 1997-02-20 Gruenenthal Gmbh Schnell zerfallende Arzneiform von Tramadol oder einem Tramadolsalz
NZ507271A (en) * 1998-03-06 2003-03-28 Eurand Internat S Fast disintegrating tablets
EP1739072A1 (fr) 2005-06-15 2007-01-03 Laboratorios Menarini S.A. Formes polymorphiques du dexketoprofene trometamol, ainsi que leurs préparations et compositions pharmaceutiques les comprenant
EP1917000A2 (fr) 2005-07-07 2008-05-07 Farnam Companies, Inc. Compositions pharmaceutiques a liberation prolongee pour medicaments tres solubles dans l'eau
ITMI20060983A1 (it) * 2006-05-18 2007-11-19 Formevet S P A Composizioni farmaceutiche veterinarie per il trattamento del dolore e dell'inifiamazione
BRPI0700133A (pt) * 2007-01-29 2008-09-16 Incrementha P D & I Pesquisa D composição farmacêutica compreendendo tramadol e cetoprofeno em combinação
WO2008150324A1 (fr) * 2007-03-26 2008-12-11 Theraquest Biosciences, Inc. Doses subanalgésiques d'associations médicamenteuses
EP2177215A1 (fr) * 2008-10-17 2010-04-21 Laboratorios Del. Dr. Esteve, S.A. Co-cristaux de tramadol et NSAID
ES2356762B1 (es) * 2009-09-04 2011-11-24 Farmalider S.A. Composicion farmaceutica de ibuprofeno, tramadol y un aminoacido basico, procedimiento para su preparacion y utilizacion de la misma.

Also Published As

Publication number Publication date
LT2956129T (lt) 2018-06-11
RS57271B1 (sr) 2018-08-31
KR20150115803A (ko) 2015-10-14
US9949940B2 (en) 2018-04-24
ES2672986T3 (es) 2018-06-19
SA515360877B1 (ar) 2018-04-29
PH12015501766A1 (en) 2015-11-09
MY173102A (en) 2019-12-26
CL2015002251A1 (es) 2016-02-05
IL240514A0 (en) 2015-10-29
ITMI20130210A1 (it) 2014-08-15
CY1120301T1 (el) 2019-07-10
CU20150081A7 (es) 2016-01-29
MA38335B1 (fr) 2017-12-29
HRP20180974T1 (hr) 2018-08-10
EA029709B1 (ru) 2018-05-31
JP6297068B2 (ja) 2018-03-20
CN105007907A (zh) 2015-10-28
MX353897B (es) 2018-02-01
MX2015010431A (es) 2015-10-05
UA115684C2 (uk) 2017-12-11
CA2900979A1 (fr) 2014-08-21
AP2015008616A0 (en) 2015-07-31
TWI642430B (zh) 2018-12-01
IL240514B (en) 2019-10-31
EA201591319A1 (ru) 2016-01-29
HUE038417T2 (hu) 2018-10-29
WO2014124862A1 (fr) 2014-08-21
TN2015000345A1 (en) 2017-01-03
CA2900979C (fr) 2021-04-13
UY35324A (es) 2014-08-29
SG11201506291UA (en) 2015-09-29
NZ710967A (en) 2019-08-30
TW201442703A (zh) 2014-11-16
EP2956129B1 (fr) 2018-04-18
DK2956129T3 (en) 2018-06-18
CN105007907B (zh) 2017-06-09
PL2956129T3 (pl) 2018-09-28
NI201500105A (es) 2015-09-10
GEP201706649B (en) 2017-03-27
PT2956129T (pt) 2018-06-14
NO2956129T3 (fr) 2018-09-15
KR102262408B1 (ko) 2021-06-08
TR201810114T4 (tr) 2018-08-27
BR112015018952A2 (pt) 2017-07-18
EP2956129A1 (fr) 2015-12-23
HK1216840A1 (zh) 2016-12-09
AU2014218110B2 (en) 2018-08-09
AU2014218110A1 (en) 2015-08-27
MA38335A1 (fr) 2016-12-30
AR094783A1 (es) 2015-08-26
BR112015018952B1 (pt) 2022-09-13
PH12015501766B1 (en) 2015-11-09
ECSP15034660A (es) 2019-03-29
CR20150411A (es) 2015-12-07
SI2956129T1 (en) 2018-06-29
US20150374650A1 (en) 2015-12-31
JP2016507577A (ja) 2016-03-10
PE20151430A1 (es) 2015-10-13

Similar Documents

Publication Publication Date Title
EA201690102A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
UA105229C2 (uk) Фармацевтичний склад
PE20140389A1 (es) Composiciones y metodos para el tratamiento de la mielofibrosis
ECSP14013200A (es) Una nueva composición terapéutica que contiene apomorfina como principio activo
CO6620015A2 (es) Composición farmacéutica que comprende un derivado de amida o sal farmacéuticamente aceptable del mismo
BR112012024428A2 (pt) composição farmacêutica de dissolução rápida
JP2013521297A5 (fr)
CU24310B1 (es) Composiciones farmacéuticas que contienen dexketoprofeno y tramadol
GR1008228B (el) Φαρμακευτικο σκευασμα περιεχον ενα διπλο αναστολεα επαναπροσληψης και μεθοδος για την παρασκευη αυτου
MX2015010434A (es) Derivados de acido bisfenil-butanoico sustituido como inhibidores de la endopeptidasa neutra (nep), con una mayor eficacia in vivo.
CY1121280T1 (el) Χρηση της θυαζολοπυριμιδινονης για τη θεραπεια της φλεγμονωδους νοσου του εντερου
RU2014146303A (ru) Способ лечения угрей
TH168478A (th) องค์ประกอบทางเภสัชกรรมที่มีเด็กซ์คีโตโพรเฟนและทรามาดอล
AR081219A1 (es) Preparacion de clorhidrato de ezatiostat cristalino ansolvatado forma d
RU2010154205A (ru) Твердая лекарственная форма препаратов мемантина и его солей
AR079128A1 (es) Procedimiento para preparar un polimorfo de la sal de colina de (4,6-bis( dimetilamino)2-(4-((4-(trifluorometil)-benzoil) amino) bencil) pirimidin-5-ilo
RU2012144715A (ru) Фармацевтическая субстанция соли аминокислоты l-лизина и эсцина
IN2013MU02366A (fr)
AR080321A1 (es) Una composicion de liberacion prolongada farmaceutica de entacapona o sus sales, proceso de preparacion y metodo de tratamiento de la enfermedad de parkinson
RU2010126737A (ru) Способ предоперационной подготовки больных тиреотоксикозом
CO6410294A2 (es) Nueva asociación de ingredientes activos que contienen un fármaco antiinflamatorio, no esteroideo y un derivado de colchicósido
RU2012148631A (ru) Композиционный препарат для профилактики пневмонии поросят